Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals

Luis M. Molinos-Albert, Jorge Carrillo, Marta Curriu, Maria L. Rodriguez de la Concepción, Silvia Marfil, Elisabet García, Bonaventura Clotet, Julià Blanco

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)

Abstract

Background: The MPER region of the HIV-1 envelope glycoprotein gp41 is targeted by broadly neutralizing antibodies. However, the localization of this epitope in a hydrophobic environment seems to hamper the elicitation of these antibodies in HIV infected individuals.We have quantified and characterized anti-MPER antibodies by ELISA and by flow cytometry using a collection of mini gp41-derived proteins expressed on the surface of 293T cells. Longitudinal plasma samples from 35 HIV-1 infected individuals were assayed for MPER recognition and MPER-dependent neutralizing capacity using HIV-2 viruses engrafted with HIV-1 MPER sequences.Results: Miniproteins devoid of the cysteine loop of gp41 exposed the MPER on 293T cell membrane. Anti-MPER antibodies were identified in most individuals and were stable when analyzed in longitudinal samples. The magnitude of the responses was strongly correlated with the global response to the HIV-1 envelope glycoprotein, suggesting no specific limitation for anti-MPER antibodies. Peptide mapping showed poor recognition of the C-terminal MPER moiety and a wide presence of antibodies against the 2F5 epitope. However, antibody titers failed to correlate with 2F5-blocking activity and, more importantly, with the specific neutralization of HIV-2 chimeric viruses bearing the HIV-1 MPER sequence; suggesting a strong functional heterogeneity in anti-MPER humoral responses.Conclusions: Anti-MPER antibodies can be detected in the vast majority of HIV-1 infected individuals and are generated in the context of the global anti-Env response. However, the neutralizing capacity is heterogeneous suggesting that eliciting neutralizing anti-MPER antibodies by immunization might require refinement of immunogens to skip nonneutralizing responses. © 2014 Molinos-Albert et al.; licensee BioMed Central Ltd.
Original languageEnglish
Article number44
JournalRetrovirology
Volume11
Issue number1
DOIs
Publication statusPublished - 7 Jun 2014

Fingerprint Dive into the research topics of 'Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals'. Together they form a unique fingerprint.

  • Cite this

    Molinos-Albert, L. M., Carrillo, J., Curriu, M., Rodriguez de la Concepción, M. L., Marfil, S., García, E., Clotet, B., & Blanco, J. (2014). Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals. Retrovirology, 11(1), [44]. https://doi.org/10.1186/1742-4690-11-44